Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Novel Common Genetic Susceptibility Loci for Colorectal Cancer.

Schmit SL, Edlund CK, Schumacher FR, Gong J, Harrison TA, Huyghe JR, Qu C, Melas M, Van Den Berg DJ, Wang H, Tring S, Plummer SJ, Albanes D, Alonso MH, Amos CI, Anton K, Aragaki AK, Arndt V, Barry EL, Berndt SI, Bezieau S, Bien S, Bloomer A, Boehm J, Boutron-Ruault MC, Brenner H, Brezina S, Buchanan DD, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Castelao JE, Chan AT, Chang-Claude J, Chanock SJ, Cheng I, Cheng YW, Chin LS, Church JM, Church T, Coetzee GA, Cotterchio M, Cruz Correa M, Curtis KR, Duggan D, Easton DF, English D, Feskens EJM, Fischer R, FitzGerald LM, Fortini BK, Fritsche LG, Fuchs CS, Gago-Dominguez M, Gala M, Gallinger SJ, Gauderman WJ, Giles GG, Giovannucci EL, Gogarten SM, Gonzalez-Villalpando C, Gonzalez-Villalpando EM, Grady WM, Greenson JK, Gsur A, Gunter M, Haiman CA, Hampe J, Harlid S, Harju JF, Hayes RB, Hofer P, Hoffmeister M, Hopper JL, Huang SC, Huerta JM, Hudson TJ, Hunter DJ, Idos GE, Iwasaki M, Jackson RD, Jacobs EJ, Jee SH, Jenkins MA, Jia WH, Jiao S, Joshi AD, Kolonel LN, Kono S, Kooperberg C, Krogh V, Kuehn T, Küry S, LaCroix A, Laurie CA, Lejbkowicz F, Lemire M, Lenz HJ, Levine D, Li CI, Li L, Lieb W, Lin Y, Lindor NM, Liu YR, Loupakis F, Lu Y, Luh F, Ma J, Mancao C, Manion FJ, Markowitz SD, Martin V, Matsuda K, Matsuo K, McDonnell KJ, McNeil CE, Milne R, Molina AJ, Mukherjee B, Murphy N, Newcomb PA, Offit K, Omichessan H, Palli D, Cotoré JPP, Pérez-Mayoral J, Pharoah PD, Potter JD, Qu C, Raskin L, Rennert G, Rennert HS, Riggs BM, Schafmayer C, Schoen RE, Sellers TA, Seminara D, Severi G, Shi W, Shibata D, Shu XO, Siegel EM, Slattery ML, Southey M, Stadler ZK, Stern MC, Stintzing S, Taverna D, Thibodeau SN, Thomas DC, Trichopoulou A, Tsugane S, Ulrich CM, van Duijnhoven FJB, van Guelpan B, Vijai J, Virtamo J, Weinstein SJ, White E, Win AK, Wolk A, Woods M, Wu AH, Wu K, Xiang YB, Yen Y, Zanke BW, Zeng YX, Zhang B, Zubair N, Kweon SS, Figueiredo JC, Zheng W, Marchand LL, Lindblom A, Moreno V, Peters U, Casey G, Hsu L, Conti DV, Gruber SB.

J Natl Cancer Inst. 2019 Feb 1;111(2):146-157. doi: 10.1093/jnci/djy099.

2.

Multiple functional risk variants in a SMAD7 enhancer implicate a colorectal cancer risk haplotype.

Fortini BK, Tring S, Plummer SJ, Edlund CK, Moreno V, Bresalier RS, Barry EL, Church TR, Figueiredo JC, Casey G.

PLoS One. 2014 Nov 6;9(11):e111914. doi: 10.1371/journal.pone.0111914. eCollection 2014.

3.

Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1.

Biancolella M, Fortini BK, Tring S, Plummer SJ, Mendoza-Fandino GA, Hartiala J, Hitchler MJ, Yan C, Schumacher FR, Conti DV, Edlund CK, Noushmehr H, Coetzee SG, Bresalier RS, Ahnen DJ, Barry EL, Berman BP, Rice JC, Coetzee GA, Casey G.

Hum Mol Genet. 2014 Apr 15;23(8):2198-209. doi: 10.1093/hmg/ddt584. Epub 2013 Nov 20.

4.

HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease.

Witte JS, Mefford J, Plummer SJ, Liu J, Cheng I, Klein EA, Rybicki BA, Casey G.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):675-80. doi: 10.1158/1055-9965.EPI-12-1154. Epub 2013 Feb 8.

5.

Association of the innate immunity and inflammation pathway with advanced prostate cancer risk.

Kazma R, Mefford JA, Cheng I, Plummer SJ, Levin AM, Rybicki BA, Casey G, Witte JS.

PLoS One. 2012;7(12):e51680. doi: 10.1371/journal.pone.0051680. Epub 2012 Dec 14.

6.

Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry.

Cicek MS, Lindor NM, Gallinger S, Bapat B, Hopper JL, Jenkins MA, Young J, Buchanan D, Walsh MD, Le Marchand L, Burnett T, Newcomb PA, Grady WM, Haile RW, Casey G, Plummer SJ, Krumroy LA, Baron JA, Thibodeau SN.

J Mol Diagn. 2011 May;13(3):271-81. doi: 10.1016/j.jmoldx.2010.12.004.

7.

FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans.

Nock NL, Plummer SJ, Thompson CL, Casey G, Li L.

Carcinogenesis. 2011 May;32(5):748-56. doi: 10.1093/carcin/bgr026. Epub 2011 Feb 11.

8.

Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35.

Liu X, Cheng I, Plummer SJ, Suarez BK, Casey G, Catalona WJ, Witte JS.

Prostate. 2011 May 15;71(7):682-9. doi: 10.1002/pros.21284. Epub 2010 Oct 13.

9.

Prostate cancer susceptibility variants confer increased risk of disease progression.

Cheng I, Plummer SJ, Neslund-Dudas C, Klein EA, Casey G, Rybicki BA, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2124-32. doi: 10.1158/1055-9965.EPI-10-0268. Epub 2010 Jul 22.

10.

Interleukin-22 genetic polymorphisms and risk of colon cancer.

Thompson CL, Plummer SJ, Tucker TC, Casey G, Li L.

Cancer Causes Control. 2010 Aug;21(8):1165-70. doi: 10.1007/s10552-010-9542-5. Epub 2010 Mar 26.

PMID:
20339910
11.

No Association of Obesity and Type 2 Diabetes Mellitus Related Genetic Variants With Colon Cancer.

Thompson CL, Plummer SJ, Tucker TC, Casey G, Li L.

Gastroenterology Res. 2009 Dec;2(6):311-316. Epub 2009 Nov 20.

12.

No association between phosphatase and tensin homolog genetic polymorphisms and colon cancer.

Phillips LS, Thompson CL, Merkulova A, Plummer SJ, Tucker TC, Casey G, Li L.

World J Gastroenterol. 2009 Aug 14;15(30):3771-5.

13.

No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.

Thompson CL, Plummer SJ, Merkulova A, Cheng I, Tucker TC, Casey G, Li L.

World J Gastroenterol. 2009 May 14;15(18):2240-4.

14.

Association of common genetic variants in SMAD7 and risk of colon cancer.

Thompson CL, Plummer SJ, Acheson LS, Tucker TC, Casey G, Li L.

Carcinogenesis. 2009 Jun;30(6):982-6. doi: 10.1093/carcin/bgp086. Epub 2009 Apr 8.

15.

Pathological aggressiveness of prostatic carcinomas related to RNASEL R462Q allelic variants.

Larson BT, Magi-Galluzzi C, Casey G, Plummer SJ, Silverman R, Klein EA.

J Urol. 2008 Apr;179(4):1344-8. doi: 10.1016/j.juro.2007.11.078. Epub 2008 Mar 4.

16.

A common 8q24 variant and the risk of colon cancer: a population-based case-control study.

Li L, Plummer SJ, Thompson CL, Merkulova A, Acheson LS, Tucker TC, Casey G.

Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):339-42. doi: 10.1158/1055-9965.EPI-07-0713.

17.

Association between phosphatidylinositol 3-kinase regulatory subunit p85alpha Met326Ile genetic polymorphism and colon cancer risk.

Li L, Plummer SJ, Thompson CL, Tucker TC, Casey G.

Clin Cancer Res. 2008 Feb 1;14(3):633-7. doi: 10.1158/1078-0432.CCR-07-1211. Review. Erratum in: Clin Cancer Res. 2008 Dec 1;14(23):7963.

18.

8q24 and prostate cancer: association with advanced disease and meta-analysis.

Cheng I, Plummer SJ, Jorgenson E, Liu X, Rybicki BA, Casey G, Witte JS.

Eur J Hum Genet. 2008 Apr;16(4):496-505. doi: 10.1038/sj.ejhg.5201959. Epub 2008 Jan 30.

19.

COX2 genetic variation, NSAIDs, and advanced prostate cancer risk.

Cheng I, Liu X, Plummer SJ, Krumroy LM, Casey G, Witte JS.

Br J Cancer. 2007 Aug 20;97(4):557-61. Epub 2007 Jul 3.

20.

Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer.

Zhao Z, Xiao Y, Elson P, Tan H, Plummer SJ, Berk M, Aung PP, Lavery IC, Achkar JP, Li L, Casey G, Xu Y.

J Clin Oncol. 2007 Jul 1;25(19):2696-701.

PMID:
17602074
21.

MIC1 and IL1RN genetic variation and advanced prostate cancer risk.

Cheng I, Krumroy LM, Plummer SJ, Casey G, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1309-11. No abstract available.

22.

Reduced expression of autotaxin predicts survival in uveal melanoma.

Singh AD, Sisley K, Xu Y, Li J, Faber P, Plummer SJ, Mudhar HS, Rennie IG, Kessler PM, Casey G, Williams BG.

Br J Ophthalmol. 2007 Oct;91(10):1385-92. Epub 2007 May 2.

23.

Toll-like receptor 4 genetic variation and advanced prostate cancer risk.

Cheng I, Plummer SJ, Casey G, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):352-5.

24.

Association of testis derived transcript gene variants and prostate cancer risk.

Liu X, Cicek MS, Plummer SJ, Jorgenson E, Casey G, Witte JS.

J Urol. 2007 Mar;177(3):894-8.

PMID:
17296370
25.

Trans-fatty acid intake and increased risk of advanced prostate cancer: modification by RNASEL R462Q variant.

Liu X, Schumacher FR, Plummer SJ, Jorgenson E, Casey G, Witte JS.

Carcinogenesis. 2007 Jun;28(6):1232-6. Epub 2007 Jan 18.

PMID:
17234723
26.

Ascending the learning curve--MSI testing experience of a six-laboratory consortium.

Lindor NM, Smalley R, Barker M, Bigler J, Krumroy LM, Lum-Jones A, Plummer SJ, Selander T, Thomas S, Youash M, Seminara D, Casey G, Bapat B, Thibodeau SN.

Cancer Biomark. 2006;2(1-2):5-9.

PMID:
17192055
27.

Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha.

Liu X, Plummer SJ, Nock NL, Casey G, Witte JS.

Am J Epidemiol. 2006 Nov 15;164(10):984-9. Epub 2006 Aug 24.

PMID:
16931544
28.

Polymorphisms in polycyclic aromatic hydrocarbon metabolism and conjugation genes, interactions with smoking and prostate cancer risk.

Nock NL, Liu X, Cicek MS, Li L, Macarie F, Rybicki BA, Plummer SJ, Maclennan GT, Casey G, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):756-61.

29.

Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.

Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, Malathi K, Magi-Galluzzi C, Tubbs RR, Ganem D, Silverman RH, DeRisi JL.

PLoS Pathog. 2006 Mar;2(3):e25. Epub 2006 Mar 31. Retraction in: PLoS Pathog. 2012 Sep;8(9). doi: 10.1371/annotation/7e2efc01-2e9b-4e9b-aef0-87ab0e4e4732.

30.

Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk.

Nock NL, Cicek MS, Li L, Liu X, Rybicki BA, Moreira A, Plummer SJ, Casey G, Witte JS.

Carcinogenesis. 2006 Sep;27(9):1842-8. Epub 2006 Mar 28.

PMID:
16569655
31.

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness.

Casey G, Neville PJ, Liu X, Plummer SJ, Cicek MS, Krumroy LM, Curran AP, McGreevy MR, Catalona WJ, Klein EA, Witte JS.

Hum Mol Genet. 2006 Mar 1;15(5):735-41. Epub 2006 Jan 24.

PMID:
16434482
32.

CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer.

Plummer SJ, Conti DV, Paris PL, Curran AP, Casey G, Witte JS.

Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):928-32.

33.

RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.

Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS.

Nat Genet. 2002 Dec;32(4):581-3. Epub 2002 Nov 4.

PMID:
12415269
34.

Germline BRCA1 alterations in a population-based series of ovarian cancer cases.

Janezic SA, Ziogas A, Krumroy LM, Krasner M, Plummer SJ, Cohen P, Gildea M, Barker D, Haile R, Casey G, Anton-Culver H.

Hum Mol Genet. 1999 May;8(5):889-97.

35.

Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors.

Plummer SJ, Paris MJ, Myles J, Tubbs R, Crowe J, Casey G.

Genes Chromosomes Cancer. 1997 Dec;20(4):354-62.

PMID:
9408751
36.

Mapping of 228 ESTs and 26 genes into an integrated physical and genetic map of human chromosome 17.

Plummer SJ, Simmons JA, Adams L, Casey G.

Genomics. 1997 Oct 1;45(1):140-6.

PMID:
9339370
37.

Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25.

Plummer SJ, Adams L, Simmons JA, Casey G.

Oncogene. 1997 May 15;14(19):2339-45.

38.

DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies.

Casey G, Lopez ME, Ramos JC, Plummer SJ, Arboleda MJ, Shaughnessy M, Karlan B, Slamon DJ.

Oncogene. 1996 Nov 7;13(9):1971-81.

PMID:
8934544
39.

Are we any closer to genetic testing for common malignancies?

Plummer SJ, Casey G.

Nat Med. 1996 Feb;2(2):156-8. No abstract available.

PMID:
8574954
40.

Detection of BRCA1 mutations by the protein truncation test.

Plummer SJ, Anton-Culver H, Webster L, Noble B, Liao S, Kennedy A, Belinson J, Casey G.

Hum Mol Genet. 1995 Oct;4(10):1989-91. No abstract available.

PMID:
8595428
41.

A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.

Plummer SJ, Santibáñez-Koref M, Kurosaki T, Liao S, Noble B, Fain PR, Anton-Culver H, Casey G.

Oncogene. 1994 Nov;9(11):3273-80.

PMID:
7936651

Supplemental Content

Loading ...
Support Center